Researchers develop novel selenium nanoparticles for managing postmenopausal osteoporosis

As the aging population around the world grows, metabolic diseases like osteoporosis are becoming more prevalent and placing a greater burden on health care systems. Rising to this challenge, a research team led by Prof. Wong Ka-hing, Director of the Research Institute for Future Food and Professor of the Department of Food Science and Nutrition at The Hong Kong Polytechnic University (PolyU), has developed novel selenium nanoparticles (Cs4-SeNPs) for managing postmenopausal osteoporosis.